–News Direct– Volta Metals Ltd (CSE:VLTA) President and CEO Kerem Usenmez speaks to Thomas Warner from Proactive London after the Canadian lithium explorer announced the discovery of new lithium-bearing pegmatite at its Falcon West Lithium Project in Ontario. Usenmez explains that the discovery of lithium-bearing pegmatite is the third in around a month at Falcon […]
Tiziana Life Sciences reports six-month PET scan results for MS patients
–News Direct– Tiziana Life Sciences Ltd (NASDAQ:TLSA) chief medical officer and chief operating officer Matthew Davis speaks to Thomas Warner from Proactive after the clinical-stage biopharmaceutical company announced an update on the company's progress in treating non-active secondary progressive multiple sclerosis (MS). The latest six-month PET scan data reveals improvements in five out of six […]
Allied Gold Corp CFO lays out ambitious expansion plans for African assets
–News Direct– Allied Gold Corp (TSX:AAUC) Chief Financial Officer Jason LeBlanc speaks to Thomas Warner from Proactive about the future of a business that describes itself as Africa's fastest-growing gold producer. LeBlanc explains that Allied Gold Corp is a newly public entity, having recently listed on the Toronto Stock Exchange. The company boasts a current […]
IQGeo Group anticipating “much higher growth in software revenues”
–News Direct– IQGeo Group PLC (AIM:IQG) chief executive Richard Petti and chief financial officer Haywood Chapman speak to Thomas Warner from Proactive after releasing the software developer's half-year report for the six months to 30 June 2023. Petti starts by addressing the Group's acquisition of fewer new clients compared to previous years, highlighting that the […]
Annamite Resources working with Rio Tinto in “underexplored” Laos
–News Direct– Annamite Resources CEO Didier Fohlen speaks to Thomas Warner from Proactive London about the work the junior explorer has been doing in Laos since being founded in 2019 Fohlen explains the reason for the focus on Laos, describing it as significantly under-explored, with only 10% of the country having been "properly assessed" by […]
Southern Cross Britannia upbeat on lithium brine prospects in Argentina
–News Direct– Southern Cross Britannia Founder, President, Director and CEO Christian Mbius visits the Proactive London studio to speak with Thomas Warner about the mineral exploration company's mission and projects. Founded to capitalise on the shift towards renewable energy and electric mobility, the company has honed in on Argentina, a region that Mbius describes as […]
Mont Royal Resources hoping to keep exploring into the winter
–News Direct– Mont Royal Resources Ltd (ASX:MRZ) Executive Director Peter Ruse speaks to Thomas Warner from Proactive about the company's exploration activities in the James Bay area of Quebec, Canada. Since their initial acquisition in the region in 2019, they have expanded their focus from copper and gold to include lithium exploration, in response to […]
MT Tower Elevates the Metaverse Experience: Listed on MEXC Exchange and Redefining Engagement, Authenticity, and Inclusivity
–News Direct– The metaverse is ablaze with excitement and innovation, and standing tall at the forefront of this digital revolution is none other than MT Tower. MT Tower is poised to transform the influencer and social media landscape into a vibrant and immersive wonderland. With a commitment to cutting-edge innovation, MT Tower aims to deliver […]
SSV Capital NED reveals high hopes ahead of SmartPay soft launch
–News Direct– SSV Capital Non-Executive Director David Lewis visits the Proactive London studio to speak with Thomas Warner about the emerging company's core mission and pillars. SSV Capital is a portfolio company with an underlying ESG (Environmental, Social, and Governance) focus that emphasises the intertwined importance of people, planet, and prosperity. The firm operates on […]
Faron Pharmaceuticals CEO delighted with latest BEXMAB study findings
–News Direct– Faron Pharmaceuticals Limited (AIM:FARN, OTC:FPHAF) chief executive Dr Markku Jalkanen speaks to Thomas Warner from Proactive London after the clinical stage biopharmaceutical company revealed fresh data from the company's ongoing phase I/II trial. Its BEXMAB study is evaluating the efficacy of bexmarilimab in treating acute myeloid leukaemia (AML) and myelodysplastic syndromes (MDS). Jalkanen […]